Human Clinical Trials Are Up Next for Experimental HIV Vaccine

Black people account for a higher proportion of new HIV diagnoses, those living with HIV, and those who have ever received an AIDS diagnosis, compared to other races and ethnicities. In 2016, African Americans accounted for 44% of HIV diagnoses, though we only make up 12% of the U.S. population.

When you read those stats, it makes you wonder, will there ever be a cure or something solid in place to prevent contracting the virus?

According to U.S. researchers, an experimental HIV vaccine protected animals from dozens of strains of HIV and a human trial of the vaccine is expected to begin in the second half of 2019.

The vaccine targets a vulnerable site on HIV, the virus that causes AIDS, and triggered antibody production in mice, guinea pigs, and monkeys, according to researchers with the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

The scientists “used their detailed knowledge of the